Summit Therapeutics (SMMT) shares outstanding

Shares outstanding · fiscal 2025
747.70M

Summit Therapeutics (SMMT) had 747.70M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 4.1% higher than the 718.54M of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
747.70M
Change on fiscal 2024
+4.1%
Growth, 5 years
+60.8% a year
Highest on record
747.70Mfiscal 2025
Lowest on record
17.23Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Summit Therapeutics shares outstanding, in more detail

The market data feed counts 799.76M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 60.8% a year. Across the 7 fiscal years on record (2019–2025), the highest was 747.70M in fiscal 2025 and the lowest 17.23M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

Summit Therapeutics shares outstanding, year by year

Summit Therapeutics (SMMT) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025747.70M 4.1% up
2024718.54M 16.0% up
2023619.65M 220.5% up
2022193.34M 46.8% up
2021131.71M 89.5% up
202069.52M 303.5% up
201917.23M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Summit Therapeutics and comparable companies
CompanyShares outstandingFiscal year
BridgeBio Pharma BBIO191.53M2025
Summit Therapeutics SMMT747.70M2025
Glaukos GKOS57.19M2025
Encompass Health EHC102.20M2025
BrightSpring Health Services BTSG219.77M2025
Baxter International BAX513.00M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SMMT

Summit Therapeutics, figure by figure

Summit Therapeutics (SMMT) overview: price, valuation and scorecardAll health care companies by market value

Summit Therapeutics shares outstanding: questions and answers

How many shares does Summit Therapeutics have?

Summit Therapeutics (SMMT) had 747.70M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 4.1% higher than the 718.54M of fiscal 2024. The market data feed counts 799.76M shares outstanding today.

What is the growth rate of Summit Therapeutics's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 60.8% a year.

What are the highest and lowest diluted share count figures on record for Summit Therapeutics?

Across the 7 fiscal years on record (2019–2025), the highest was 747.70M in fiscal 2025 and the lowest 17.23M in fiscal 2019.

How is Summit Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Summit Therapeutics it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Summit Therapeutics (SMMT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/SMMT/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.